article
The success story of Mapp Pharmaceuticals’ experimental drug, ZMapp, during…
3 December 2015 | By Huafang Lai (Arizona State University), Qiang “Shawn” Chen (Arizona State University)
The success story of Mapp Pharmaceuticals’ experimental drug, ZMapp, during last year’s Ebola outbreak highlights the potential of plant-made monoclonal antibodies (mAbs) as life-saving treatments.